• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Weiss steps down at Lumisys

Article

Lumisys CEO Stephen Weiss has left the company, the Sunnyvale, CA, film-digitizer developer announced March 6. The reason for his departure was his desire to focus on working with smaller, privately held companies, Weiss said. Lumisys chairman Douglas

Lumisys CEO Stephen Weiss has left the company, the Sunnyvale, CA, film-digitizer developer announced March 6. The reason for his departure was his desire to focus on working with smaller, privately held companies, Weiss said. Lumisys chairman Douglas DeVivo has been named CEO.

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.